AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...
Nara Smith shared pictures of her recent eczema flare-ups on Instagram, where the model got candid about her journey with the ...
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...
AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary ...
Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...
Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...
Being a social media star may seem like the high life but Nara Smith, fashion model-turned-TikTok creator just pulled back the curtain on all that appears glitz and glam by getting candid about her ...
AnaptysBio is dropping its atopic dermatitis (AD) drug candidate after the compound failed to reduce eczema area and itch ...
Nara Smith, known for her picture-perfect content, has opened up about her health challenges, saying it inspired her to start ...
Famed for her incredible IG cook-a-longs, model Nara Smith has been opening up about her battles with skin condition eczema.
Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study published ...